Literature DB >> 11515701

Anxiety and the schizophrenic process: clinical and epidemiological evidence.

G Turnbull1, P Bebbington.   

Abstract

BACKGROUND: The authors hypothesise that anxiety is an integral part of the development of schizophrenia in a significant sub-group of cases. This paper reviews the evidence for an epidemiological link between anxiety and schizophrenia, emphasising those studies that imply a temporal sequence.
METHOD: An augmented systematic search of electronic databases was conducted, and the methods and results of the studies identified were reviewed.
RESULTS: Panic disorder was identified in around 20% of cases of schizophrenia in clinical studies (range 5-33 %). Other anxiety disorders were less often studied, but were also frequent. Epidemiological studies from the Epidemiological Catchment Area Program confirm the strong association between anxiety disorders and schizophrenia. Finally, cohort studies identify anxiety as an early antecedent of schizophrenia.
CONCLUSION: There is a significant link between anxiety and schizophrenia. This may represent a psychological process integral to an appreciable number of cases of schizophrenia. Focused psychological studies are needed to determine whether this is so.

Entities:  

Mesh:

Year:  2001        PMID: 11515701     DOI: 10.1007/s001270170054

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  13 in total

1.  Prevalence and correlates of psychotic symptoms among Asian males.

Authors:  Mythily Subramaniam; Swapna Verma; Christopher Cheok; I-Min Lee; John Wong; Siow Ann Chong
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2010-11-03       Impact factor: 4.328

Review 2.  Cognitive, emotional, and social processes in psychosis: refining cognitive behavioral therapy for persistent positive symptoms.

Authors:  Elizabeth Kuipers; Philippa Garety; David Fowler; Daniel Freeman; Graham Dunn; Paul Bebbington
Journal:  Schizophr Bull       Date:  2006-08-02       Impact factor: 9.306

3.  EEG microstate analysis in drug-naive patients with panic disorder.

Authors:  Mitsuru Kikuchi; Thomas Koenig; Toshio Munesue; Akira Hanaoka; Werner Strik; Thomas Dierks; Yoshifumi Koshino; Yoshio Minabe
Journal:  PLoS One       Date:  2011-07-29       Impact factor: 3.240

4.  The neuroanatomical basis of panic disorder and social phobia in schizophrenia: a voxel based morphometric study.

Authors:  Marisol Picado; Susanna Carmona; Elseline Hoekzema; Guillem Pailhez; Daniel Bergé; Anna Mané; Jordi Fauquet; Joseph Hilferty; Ana Moreno; Romina Cortizo; Oscar Vilarroya; Antoni Bulbena
Journal:  PLoS One       Date:  2015-03-16       Impact factor: 3.240

Review 5.  The evolution of cognitive-behavioral therapy for psychosis.

Authors:  Helen Mander; David Kingdon
Journal:  Psychol Res Behav Manag       Date:  2015-02-18

6.  Phenotypic Manifestation of Genetic Risk for Schizophrenia During Adolescence in the General Population.

Authors:  Hannah J Jones; Evie Stergiakouli; Katherine E Tansey; Leon Hubbard; Jon Heron; Mary Cannon; Peter Holmans; Glyn Lewis; David E J Linden; Peter B Jones; George Davey Smith; Michael C O'Donovan; Michael J Owen; James T Walters; Stanley Zammit
Journal:  JAMA Psychiatry       Date:  2016-03       Impact factor: 21.596

7.  Comprehensive behavioral analysis of pituitary adenylate cyclase-activating polypeptide (PACAP) knockout mice.

Authors:  Satoko Hattori; Keizo Takao; Koichi Tanda; Keiko Toyama; Norihito Shintani; Akemichi Baba; Hitoshi Hashimoto; Tsuyoshi Miyakawa
Journal:  Front Behav Neurosci       Date:  2012-10-02       Impact factor: 3.558

8.  ENU-mutagenesis mice with a non-synonymous mutation in Grin1 exhibit abnormal anxiety-like behaviors, impaired fear memory, and decreased acoustic startle response.

Authors:  Juzoh Umemori; Keizo Takao; Hisatsugu Koshimizu; Satoko Hattori; Tamio Furuse; Shigeharu Wakana; Tsuyoshi Miyakawa
Journal:  BMC Res Notes       Date:  2013-05-21

Review 9.  Anxiety disorders and schizophrenia.

Authors:  Jacqueline E Muller; Liezl Koen; Seedat Soraya; Robin A Emsley; Daniel J Stein
Journal:  Curr Psychiatry Rep       Date:  2004-08       Impact factor: 8.081

10.  The alkaloid alstonine: a review of its pharmacological properties.

Authors:  E Elisabetsky; L Costa-Campos
Journal:  Evid Based Complement Alternat Med       Date:  2006-01-16       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.